mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-13 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-10 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-10 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-10 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-10 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-09 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |